---
schema_version: "secwatch.filing_event.v1"
accession: "0001601830-25-000008"
form_type: "8-K"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:22:03.052377+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Recursion Pharmaceuticals releases updated investor presentation for JP Morgan Healthcare Conference

## Summary
- Investor presentation dated January 13, 2025 attached as Exhibit 99.1
- Presentation to be used at JP Morgan Healthcare Conference and in investor meetings
- CEO Christopher Gibson signed the 8-K filing on January 13, 2025
- Information furnished under Item 7.01 not deemed filed for SEC purposes

## SEC filing metadata
- accession: 0001601830-25-000008
- form_type: 8-K
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000008/0001601830-25-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000008/rxrx-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601830-25-000008
- JSON: https://secwatch.observer/filing/0001601830-25-000008.json
- Plain text: https://secwatch.observer/filing/0001601830-25-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.